UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence Patterns and Survival of Gynecological Sarcoma in Germany: Analysis of Population-Based Cancer Registry Data on 1066 Women

International journal of gynecological cancer, 2018-01, Vol.28 (1), p.134-138

2018

Volltextzugriff (PDF)

Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO

BMC cancer, 2024-03, Vol.24 (1), p.380-380, Article 380

2024

Volltextzugriff (PDF)

Correction: Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO

BMC cancer, 2024-04, Vol.24 (1), p.413-413, Article 413

2024

Volltextzugriff (PDF)

Checkpoint-inhibition in ovarian cancer: rising star or just a dream?

Journal of Gynecologic Oncology, 2018, 29(6), , pp.1-11

2018

Volltextzugriff (PDF)

Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer

Frontiers in oncology, 2022-12, Vol.12, p.1014073-1014073

2022

Volltextzugriff (PDF)

Perioperative advanced haemodynamic monitoring of patients undergoing multivisceral debulking surgery: an observational pilot study

Intensive care medicine experimental, 2023-09, Vol.11 (1), p.61-61, Article 61

2023

Volltextzugriff (PDF)

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer

Journal of Gynecologic Oncology, 2014, 25(3), , pp.221-228

2014

Volltextzugriff (PDF)

Brain Metastases from Epithelial Ovarian Cancer: Overview and Optimal Management

Anticancer research, 2009-07, Vol.29 (7), p.2793-2798

2009

Volltextzugriff (PDF)

Reply to M Lee

Journal of Gynecologic Oncology, 2014, 25(4), , pp.354-354

2014

Volltextzugriff (PDF)

767 Cerebral metastastases in gynaecological oncology: the Charité-experience

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A267-A267

2024

Volltextzugriff (PDF)

Sexuality as a prognostic factor: Results of an individual participant data NOGGO-meta-analysis of 1,041 recurrent ovarian cancer patients before starting chemotherapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24128-e24128

2023

Volltextzugriff (PDF)

High-grade endometrioides Karzinom in der Bauchwand nach Sectio caesarea – Fallbericht und Literaturübersicht

Gynäkologie (Heidelberg, Germany), 2024-08, Vol.57 (8), p.555-560

2024

Volltextzugriff (PDF)

High-grade endometrioides Karzinom in der Bauchwand nach Sectio caesarea – Fallbericht und Literaturübersicht: Mögliche präventive Maßnahmen gegen die iatrogene Ausbreitung von Endometriose: Wundspülung und Abdeckung der Wundränder

Gynäkologie (Heidelberg, Germany), 2024-08, Vol.57 (8), p.555-560

2024

Volltextzugriff (PDF)

SCOUT-1: Prospective non-interventional study in patients with BRCA /HRD-tested ovarian cancer (OC) eligible for first-line (1L) platinum-based chemotherapy (NOGGO ov54)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS5608-TPS5608

2022

Volltextzugriff (PDF)

1349 The predictivity of AGO score in selection for cytoreductive surgery in recurrent low-grade ovarian cancers: ‘one score fits all?’

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A426-A427

2024

Volltextzugriff (PDF)

1285 Multicenter real-world data characterizing the first recurrence of endometrial cancer

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A233-A233

2024

Volltextzugriff (PDF)

2022-RA-1154-ESGO Ovarian cancer management. Who cares for the Patient? A single case observational study

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A459-A459

2022

Volltextzugriff (PDF)

2022-RA-647-ESGO Real-word therapy and clinical and patient-reported outcomes in patients with newly diagnosed advanced ovarian cancer: first description of the SCOUT-1 study centers (NOGGO ov54, NCT04830709)

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A250-A250

2022

Volltextzugriff (PDF)

2022-RA-1438-ESGO Safety of total paracentesis in patients with malignant ascites from ovarian cancer: Results from the prospective, randomised ATLANTIS-trial

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A336-A336

2022

Volltextzugriff (PDF)

2022-RA-1287-ESGO Case report of a patient with relapsed ovarian cancer and therapy with all three approved PARP-inhibitors

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A317-A317

2022

Volltextzugriff (PDF)

Comprehensive HRD testing in epithelial ovarian cancer: A further step toward personalized therapy decisions

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17591-e17591

2023

Volltextzugriff (PDF)

First trial of chemotherapy de-escalation in ovarian cancer (OC): A phase III randomized, open label study of niraparib maintenance after carboplatin and paclitaxel in patients with optimally debulked advanced (homologous recombination deficient) HRD high-grade ovarian cancer in first line therapy (N-PLUS/NOGGO-ov53/ENGOT-ov62)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS5620-TPS5620

2023

Volltextzugriff (PDF)

PO013/#435 Role of lymphadenectomy (LND) in advanced ovarian cancer (OC) -A subgroup analysis of the patients excluded from the original lion trial (the charité cohort)

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A11-A12

2023

Volltextzugriff (PDF)

Erratum zu: Aktuelle Therapiestrategien bei malignem Aszites

Im Fokus Onkologie, 2020-06, Vol.23 (3), p.21-21

2020

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence Patterns and Survival of Gynecological Sarcoma in Germany: Analysis of Population-Based Cancer Registry Data on 1066 Women

Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO

Correction: Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO

Checkpoint-inhibition in ovarian cancer: rising star or just a dream?

Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer

Perioperative advanced haemodynamic monitoring of patients undergoing multivisceral debulking surgery: an observational pilot study

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer

Brain Metastases from Epithelial Ovarian Cancer: Overview and Optimal Management

Reply to M Lee

767 Cerebral metastastases in gynaecological oncology: the Charité-experience

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Sexuality as a prognostic factor: Results of an individual participant data NOGGO-meta-analysis of 1,041 recurrent ovarian cancer patients before starting chemotherapy

High-grade endometrioides Karzinom in der Bauchwand nach Sectio caesarea – Fallbericht und Literaturübersicht

High-grade endometrioides Karzinom in der Bauchwand nach Sectio caesarea – Fallbericht und Literaturübersicht: Mögliche präventive Maßnahmen gegen die iatrogene Ausbreitung von Endometriose: Wundspülung und Abdeckung der Wundränder

SCOUT-1: Prospective non-interventional study in patients with BRCA /HRD-tested ovarian cancer (OC) eligible for first-line (1L) platinum-based chemotherapy (NOGGO ov54)

1349 The predictivity of AGO score in selection for cytoreductive surgery in recurrent low-grade ovarian cancers: ‘one score fits all?’

1285 Multicenter real-world data characterizing the first recurrence of endometrial cancer

2022-RA-1154-ESGO Ovarian cancer management. Who cares for the Patient? A single case observational study

2022-RA-647-ESGO Real-word therapy and clinical and patient-reported outcomes in patients with newly diagnosed advanced ovarian cancer: first description of the SCOUT-1 study centers (NOGGO ov54, NCT04830709)

2022-RA-1438-ESGO Safety of total paracentesis in patients with malignant ascites from ovarian cancer: Results from the prospective, randomised ATLANTIS-trial

2022-RA-1287-ESGO Case report of a patient with relapsed ovarian cancer and therapy with all three approved PARP-inhibitors

Comprehensive HRD testing in epithelial ovarian cancer: A further step toward personalized therapy decisions

PO013/#435 Role of lymphadenectomy (LND) in advanced ovarian cancer (OC) -A subgroup analysis of the patients excluded from the original lion trial (the charité cohort)

Erratum zu: Aktuelle Therapiestrategien bei malignem Aszites

Suchergebnisse filtern